Literature DB >> 31666341

Standing at odds: mutated RAS and hematopoietic stem cells.

Monica Nafria1, Constanze Bonifer2.   

Abstract

Mesh:

Year:  2019        PMID: 31666341      PMCID: PMC6821623          DOI: 10.3324/haematol.2019.230029

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  26 in total

1.  Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t(8;21)/AML1-ETO.

Authors:  F Kuchenbauer; S Schnittger; T Look; G Gilliland; D Tenen; T Haferlach; W Hiddemann; C Buske; C Schoch
Journal:  Br J Haematol       Date:  2006-09       Impact factor: 6.998

2.  The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells.

Authors:  James C Mulloy; Jörg Cammenga; Karen L MacKenzie; Francisco J Berguido; Malcolm A S Moore; Stephen D Nimer
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

3.  N-Ras(G12D) induces features of stepwise transformation in preleukemic human umbilical cord blood cultures expressing the AML1-ETO fusion gene.

Authors:  Fu-Sheng Chou; Mark Wunderlich; Andrea Griesinger; James C Mulloy
Journal:  Blood       Date:  2011-01-03       Impact factor: 22.113

4.  In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia.

Authors:  Joseph L Wiemels; Zhijian Xiao; Patricia A Buffler; Ana T Maia; Xiaomei Ma; Brian M Dicks; Martyn T Smith; Luoping Zhang; James Feusner; John Wiencke; Kathy Pritchard-Jones; Helena Kempski; Mel Greaves
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

5.  Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients.

Authors:  Friederike Christen; Kaja Hoyer; Kenichi Yoshida; Hsin-An Hou; Nils Waldhueter; Michael Heuser; Robert K Hills; Willy Chan; Raphael Hablesreiter; Olga Blau; Yotaro Ochi; Piroska Klement; Wen-Chien Chou; Igor-Wolfgang Blau; Jih-Luh Tang; Tomasz Zemojtel; Yuichi Shiraishi; Yusuke Shiozawa; Felicitas Thol; Arnold Ganser; Bob Löwenberg; David C Linch; Lars Bullinger; Peter J M Valk; Hwei-Fang Tien; Rosemary E Gale; Seishi Ogawa; Frederik Damm
Journal:  Blood       Date:  2019-01-04       Impact factor: 22.113

6.  AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation.

Authors:  T Miyamoto; I L Weissman; K Akashi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

7.  Prognostically useful gene-expression profiles in acute myeloid leukemia.

Authors:  Peter J M Valk; Roel G W Verhaak; M Antoinette Beijen; Claudia A J Erpelinck; Sahar Barjesteh van Waalwijk van Doorn-Khosrovani; Judith M Boer; H Berna Beverloo; Michael J Moorhouse; Peter J van der Spek; Bob Löwenberg; Ruud Delwel
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

8.  Instruction of haematopoietic lineage choices, evolution of transcriptional landscapes and cancer stem cell hierarchies derived from an AML1-ETO mouse model.

Authors:  Nina Cabezas-Wallscheid; Victoria Eichwald; Jos de Graaf; Martin Löwer; Hans-Anton Lehr; Andreas Kreft; Leonid Eshkind; Andreas Hildebrandt; Yasmin Abassi; Rosario Heck; Anna Katharina Dehof; Svetlana Ohngemach; Rolf Sprengel; Simone Wörtge; Steffen Schmitt; Johannes Lotz; Claudius Meyer; Thomas Kindler; Dong-Er Zhang; Bernd Kaina; John C Castle; Andreas Trumpp; Ugur Sahin; Ernesto Bockamp
Journal:  EMBO Mol Med       Date:  2013-10-04       Impact factor: 12.137

9.  Cell-intrinsic depletion of Aml1-ETO-expressing pre-leukemic hematopoietic stem cells by K-Ras activating mutation.

Authors:  Cristina Di Genua; Ruggiero Norfo; Alba Rodriguez-Meira; Wei Xiong Wen; Roy Drissen; Christopher A G Booth; Benjamin Povinelli; Emmanouela Repapi; Nicki Gray; Joana Carrelha; Laura M Kettyle; Lauren Jamieson; Wen Hao Neo; Supat Thongjuea; Claus Nerlov; Adam J Mead
Journal:  Haematologica       Date:  2019-04-11       Impact factor: 9.941

Review 10.  'Acute myeloid leukemia: a comprehensive review and 2016 update'.

Authors:  I De Kouchkovsky; M Abdul-Hay
Journal:  Blood Cancer J       Date:  2016-07-01       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.